Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look ...

The FDA is reportedly considering the addition of high-level warning labels to COVID vaccines, a move that some experts say ...

The plan has not been finalized and may still change, CNN reported. It was not immediately clear whether the plans for the ...

The FDA intends to place a black box label—its most serious warning—on COVID-19 vaccines, according to reporting by CNN. It ...

Adjuvants help boost the immune response to the antigen in the vaccine, and can also help with dose sparing, according to a ...

The FDA will reportedly add a “black box” warning to Covid-19 vaccines as the Trump administration steps up its attack on ...

Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...

Novavax, Inc. reported a 3Q25 EPS loss and declining revenue, but beat revenue expectations and reaffirmed its FY25 guidance, driven by Sanofi partnership milestones. Novavax's heavy reliance on ...

Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...

US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to COVID-19 vaccines without data to back it up.

We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.